A detailed history of S&T Bank transactions in Novo Nordisk A S stock. As of the latest transaction made, S&T Bank holds 1,630 shares of NVO stock, worth $226,358. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,630
Holding current value
$226,358
% of portfolio
0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $166,439 - $221,549
1,630 New
1,630 $209,000
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $30,765 - $40,599
-300 Reduced 8.37%
3,285 $445,000
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $223,908 - $274,785
-2,350 Reduced 39.6%
3,585 $357,000
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $1,772 - $2,239
-21 Reduced 0.35%
5,935 $570,000
Q2 2021

Aug 13, 2021

SELL
$67.66 - $84.76 $135 - $169
-2 Reduced 0.03%
5,956 $499,000
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $536 - $606
8 Added 0.13%
5,958 $402,000
Q4 2020

Feb 17, 2021

BUY
$63.89 - $73.8 $380,145 - $439,110
5,950 New
5,950 $416,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $313B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track S&T Bank Portfolio

Follow S&T Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.